Skip to content

In the BioHarmony Drug Report Database

Fosdenopterin

Nulibry (fosdenopterin) is a small molecule pharmaceutical. Fosdenopterin was first approved as Nulibry on 2021-02-26. Nulibry's patent is valid until 2025-01-31 (FDA).
Trade Name Nulibry
Common Name Fosdenopterin
Indication
Drug Class Phosphoro-derivatives
Fosdenopterin
Get full access now